{
    "clinical_study": {
        "@rank": "129292", 
        "arm_group": [
            {
                "arm_group_label": "Integrative Chinese and western medicine", 
                "description": "Integrative Chinese and western medicine group treat with western medical therapy for CHD refering to the 'Chronic stable angina pectoris diagnosis and treatment guide'which is published by Chinese society of Cardiology, Chinese Medical Association in March, 2007, including the anti-ischemia treatment(nitric acid ester,\u03b2-blocker,calcium antagonist,ACEI), anti platelet therapy(aspirin and/or clopidogrel) and other statins.TCM should be confirmed by the physicians, according to the syndrome differentiation and the treat plan recommended in this study."
            }, 
            {
                "arm_group_label": "Western medicine", 
                "description": "western medical therapy for CHD can refer to the 'Chronic stable angina pectoris diagnosis and treatment guide'which is published by Chinese society of Cardiology, Chinese Medical Association in March, 2007, including the anti-ischemia treatment(nitric acid ester,\u03b2-blocker,calcium antagonist,ACEI), anti platelet therapy(aspirin and/or clopidogrel) and other statins."
            }
        ], 
        "brief_summary": {
            "textblock": "Compared with standardized western medical drug therapy, this study is mainly about whether\n      the combination of standardized western medical drug therapy and Chinese medical continued\n      treatment, can further decrease the rate of cardiovascular events for stable angina patients\n      and change the condition of angina."
        }, 
        "brief_title": "Effects of Integrated Treatment by Traditional Chinese and Western Medicine in Reducing Cardiovascular Events", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Angina Pectoris", 
            "Coronary Artery Disease", 
            "Coronary Disease", 
            "Heart Disease", 
            "Cardiovascular Disease", 
            "Chest Pain", 
            "Pain", 
            "Signs and Symptoms", 
            "Arteriosclerosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Angina Pectoris", 
                "Arteriosclerosis", 
                "Cardiovascular Diseases", 
                "Chest Pain", 
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease", 
                "Heart Diseases", 
                "Signs and Symptoms"
            ]
        }, 
        "detailed_description": {
            "textblock": "We will pick 1100 patients who are according with the II\u3001III stage in CHD western medical\n      diagnosis standard, treat them with combination of standardized western medical drug therapy\n      and Chinese medical continued treatment, or only with standardized western medical drug\n      therapy,the treat course will last 6 months. The patients will be separated in two groups:\n      Integrative treatment of Chinese medicine and western medicine group(integrative group) and\n      western medical group according to the exposure factors(whether the patients accept\n      differentiation of TCM ) during the follow-up period, observe the main indexes: Primary\n      Endpoint: all because of death, stroke, nonfatal myocardial infarction, revascularization.\n      Secondary endpoint: the events needed hospitalization which are because of (acute coronary\n      syndrome)ACS,heart failure, severe arrhythmia, and complications. Secondary indexes: angina\n      symptoms. Including the attack times, lasting time, inducing factors of angina attacks, pain\n      degree of angina, discontinue rate of nitroglycerin, and electrocardiogram."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. the patients who are according with the II\u3001III stage in CHD western medical diagnosis\n             standard\uff1b\n\n          2. age between 18 and 75(including 18 and 75)\uff1b\n\n          3. Signed the informed consent voluntarily.\n\n        Exclusion Criteria:\n\n          1. The patients whose systolic pressure\u2265180mmHg and/or diastolic pressure\u2265110mmHg, have\n             sever insufficiency of heart and lung\uff08cardiac function\ufe65\u2161degree\uff09, sever\n             arrhythmia\uff08rapid atrial fibrillation, atrial flutter,paroxysmal ventricular\n             tachycardia and so on\uff09\uff1b\n\n          2. the patients who have myocardial infarction or vascular remodeling in last 3 months\uff1b\n\n          3. hepatic and kidney function obstacle\uff08ALT\u3001AST>1.5 times of normal upper limit value\uff09\uff1b\n\n          4. the patients who cannot control blood glucose properly\uff08fasting blood\n             glucose>7.0mmol/L and/ or random blood glucose>11.0mmol/L\uff09\uff1b\n\n          5. the patients who have stroke in late 6 months\uff08lacunar cerebral infarction is not\n             included\uff09\uff1b\n\n          6. any other sever diseases such as malignant tumor\uff1b\n\n          7. the patients who attending other clinical study in late 3 months\uff1b\n\n          8. pregnant or lactating women\uff1b\n\n          9. the patients who have allergic constitution or are allergic to many drugs."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "treat with combination of standardized western medical drug therapy and Chinese medical\n        continued treatment"
            }
        }, 
        "enrollment": {
            "#text": "2", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01715376", 
            "org_study_id": "201007001-3-1"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "traditional chinese medicine", 
            "complementary therapies", 
            "traditional chinese medicine syndrome scale"
        ], 
        "lastchanged_date": "October 26, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Changchun", 
                    "country": "China", 
                    "state": "Jilin", 
                    "zip": "130000"
                }, 
                "name": "Jilin Province TCM Institute of Chinese Medicine"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "2", 
        "official_title": "Prospective Cohort Study on Integrated Treatment by Traditional Chinese and Western Medicine of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina", 
        "other_outcome": {
            "description": "ALT ,AST,BUN,CR,blood routine examination,urine routine", 
            "measure": "safety indicators", 
            "safety_issue": "No", 
            "time_frame": "up to 12months"
        }, 
        "overall_official": {
            "affiliation": "dirctor", 
            "last_name": "deng yue", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "China: State Administration of Traditional Chinese Medicine of the People's Republic of China", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "all because of death, stroke, nonfatal myocardial infarction, revascularization.", 
                "measure": "Primary end point all cause death", 
                "safety_issue": "No", 
                "time_frame": "up to 12 months"
            }, 
            {
                "description": "the events needed hospitalization which are because of (acute coronary syndrome)ACS,heart failure, severe arrhythmia, and complications", 
                "measure": "Secondary endpoint hospitalization", 
                "safety_issue": "No", 
                "time_frame": "up to 12months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01715376"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Changchun University of Chinese Medicine", 
            "investigator_full_name": "yue deng", 
            "investigator_title": "Director of cardiology department", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Including the attack times, lasting time, inducing factors of angina attacks, pain degree of angina, discontinue rate of nitroglycerin.", 
                "measure": "Angina symptoms", 
                "safety_issue": "No", 
                "time_frame": "up to 12months"
            }, 
            {
                "measure": "electrocardiogram", 
                "safety_issue": "No", 
                "time_frame": "up to 12months"
            }
        ], 
        "source": "Changchun University of Chinese Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Changchun University of Chinese Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2012"
    }
}